Oversea-Chinese Banking Corp (OCBC)’s Legend Biotech LEGN Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,379	Closed	-$443K	–	357
2025 Q4	$443K	Hold	20,379	–	–	0.01%	262
2025 Q3	$664K	Hold	20,379	–	–	0.02%	239
2025 Q2	$723K	Buy	+20,379	New	+$660K	0.02%	224
2024 Q4	–	Sell	-26,119	Closed	-$1.27M	–	411
2024 Q3	$1.27M	Sell	26,119 -1,035	-4%	-$55.1K	0.04%	213
2024 Q2	$1.2M	Buy	27,154 +6,248	+30%	+$288K	0.04%	199
2024 Q1	$1.17M	Buy	20,906 +11,597	+125%	+$699K	0.04%	206
2023 Q4	$560K	Buy	9,309 +2,069	+29%	+$131K	0.02%	232
2023 Q3	$486K	Buy	+7,240	New	+$503K	0.02%	272

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s LEGN Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 20,379 shares — an estimated $443K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in LEGN in Q3 2023 and held it in 8 quarters. The position peaked at $1.27M in Q3 2024. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Oversea-Chinese Banking Corp (OCBC) reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
Oversea-Chinese Banking Corp (OCBC) sold 20,379 Legend Biotech shares in Q1 2026, an estimated $443K.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Legend Biotech in Q3 2023 and held it in 8 quarters.
Oversea-Chinese Banking Corp (OCBC)'s Legend Biotech position peaked at $1.27M in Q3 2024.
191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.